Media

@article{Rabinowitz2023,

title = {Patterns of demoralization and anhedonia during early substance use disorder treatment and associations with treatment attrition},

author = {Jill A. Rabinowitz and Jennifer D. Ellis and Justin C. Strickland and Martin Hochheimer and Yijun Zhou and Andrea S. Young and Brenda Curtis and Andrew S. Huhn},

doi = {10.1016/j.jad.2023.05.029},

issn = {0165-0327},

year  = {2023},

date = {2023-08-00},

journal = {Journal of Affective Disorders},

volume = {335},

pages = {248--255},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2023b,

title = {Latent patterns of sleep disturbance, pain impact, and depressive symptoms in residential substance use treatment},

author = {Jennifer D. Ellis and Jill A. Rabinowitz. and Justin C. Strickland and Neha Skandan and J. Gregory Hobelmann and Patrick H. Finan and Andrew S. Huhn},

doi = {10.1016/j.drugalcdep.2023.109903},

issn = {0376-8716},

year  = {2023},

date = {2023-07-00},

journal = {Drug and Alcohol Dependence},

volume = {248},

publisher = {Elsevier BV},

keywords = {Pharmacology, Pharmacology (medical), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2023c,

title = {Latent patterns of sleep disturbance, pain impact, and depressive symptoms in residential substance use treatment},

author = {Jennifer D. Ellis and Jill A. Rabinowitz. and Justin C. Strickland and Neha Skandan and J. Gregory Hobelmann and Patrick H. Finan and Andrew S. Huhn},

doi = {10.1016/j.drugalcdep.2023.109903},

issn = {0376-8716},

year  = {2023},

date = {2023-07-00},

journal = {Drug and Alcohol Dependence},

volume = {248},

publisher = {Elsevier BV},

keywords = {Pharmacology, Pharmacology (medical), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2023d,

title = {Exploring potential moderators of depressive symptoms and treatment outcomes among patients with opioid use disorder},

author = {Jennifer D. Ellis and Jamey J. Lister and Michael J.A. Wohl and Mark K. Greenwald and David M. Ledgerwood},

doi = {10.1016/j.addbeh.2022.107604},

issn = {0306-4603},

year  = {2023},

date = {2023-05-00},

journal = {Addictive Behaviors},

volume = {140},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Carr2022,

title = {Childhood Adversity, Addiction Severity, and Comorbidity Among Patients Receiving Opioid Use Disorder Treatment},

author = {Meagan M. Carr and Jennifer D. Ellis and Karen K. Saules and David M. Ledgerwood},

doi = {10.1097/nmd.0000000000001581},

issn = {1539-736X},

year  = {2023},

date = {2023-00-00},

journal = {J Nerv Ment Dis},

volume = {211},

number = {2},

pages = {150--156},

publisher = {Ovid Technologies (Wolters Kluwer Health)},

abstract = {Abstract

          Patients in opioid use disorder (OUD) treatment report high rates of childhood adversity, and women experience greater exposure to certain types of childhood adversity (e.g., sexual abuse). Childhood adversity is associated with clinical severity, but the mechanisms explaining this association are not well understood. Participants (N = 171) in opioid agonist treatment completed measures of childhood adversity, emotion regulation, and clinical severity (i.e., addictive behaviors, depression, and anxiety). Women endorsed greater childhood adversity and higher current psychopathology than men. The association between childhood adversity and clinical severity varied as a function of symptom type, although emotion regulation was a strong predictor in all models. Women reported higher levels of anxiety after controlling for covariates, childhood adversity, and emotion dysregulation. Future research should investigate treatment strategies to address emotion dysregulation among patients in OUD treatment, particularly women who may present with greater childhood adversity exposure and anxiety.},

keywords = {Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2022c,

title = {Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder},

author = {Jennifer D. Ellis and Chung Jung Mun and David H. Epstein and Karran A. Phillips and Patrick H. Finan and Kenzie L. Preston},

doi = {10.1038/s41386-022-01352-y},

issn = {1740-634X},

year  = {2022},

date = {2022-09-00},

journal = {Neuropsychopharmacol.},

volume = {47},

number = {10},

pages = {1836--1843},

publisher = {Springer Science and Business Media LLC},

keywords = {Pharmacology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Lister2022,

title = {Protective Factor Predictors of Abstinence and Retention in Patients Receiving Methadone Treatment for Opioid Use Disorder},

author = {Jamey J. Lister and Jennifer D. Ellis and Cara A. Struble and David M. Ledgerwood and Mark K. Greenwald},

doi = {10.1007/s11469-022-00893-z},

issn = {1557-1882},

year  = {2022},

date = {2022-08-08},

journal = {Int J Ment Health Addiction},

publisher = {Springer Science and Business Media LLC},

keywords = {Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Huhn2022,

title = {Patient-reported sleep outcomes in randomized-controlled trials in persons with substance use disorders: A systematic review},

author = {Andrew S. Huhn and Jennifer D. Ellis and Kelly E. Dunn and Dennis J. Sholler and Paula Tabaschek and Rachel Burns and Eric C. Strain},

doi = {10.1016/j.drugalcdep.2022.109508},

issn = {0376-8716},

year  = {2022},

date = {2022-08-00},

journal = {Drug and Alcohol Dependence},

volume = {237},

publisher = {Elsevier BV},

keywords = {Pharmacology, Pharmacology (medical), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Huhn2022b,

title = {Objective sleep outcomes in randomized-controlled trials in persons with substance use disorders: A systematic review},

author = {Andrew S. Huhn and Kelly E. Dunn and Jennifer D. Ellis and Dennis J. Sholler and Paula Tabaschek and Rachel Burns and Eric C. Strain},

doi = {10.1016/j.drugalcdep.2022.109509},

issn = {0376-8716},

year  = {2022},

date = {2022-08-00},

journal = {Drug and Alcohol Dependence},

volume = {237},

publisher = {Elsevier BV},

keywords = {Pharmacology, Pharmacology (medical), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2022b,

title = {Latent trajectories of anxiety and depressive symptoms among adults in early treatment for nonmedical opioid use},

author = {Jennifer D. Ellis and Jill A. Rabinowitz and Jonathan Wells and Fangyu Liu and Patrick H. Finan and Michael D. Stein and Denis G. Antoine II and Gregory J. Hobelmann and Andrew S. Huhn},

doi = {10.1016/j.jad.2021.12.004},

issn = {0165-0327},

year  = {2022},

date = {2022-02-00},

journal = {Journal of Affective Disorders},

volume = {299},

pages = {223--232},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021b,

title = {Clinical correlates of drug‐related dreams in opioid use disorder},

author = {Jennifer D. Ellis and Jami L. Mayo and Patrick H. Finan and Charlene E. Gamaldo and Andrew S. Huhn},

doi = {10.1111/ajad.13219},

issn = {1521-0391},

year  = {2022},

date = {2022-01-00},

journal = {American J Addict},

volume = {31},

number = {1},

pages = {37--45},

publisher = {Wiley},

abstract = {AbstractBackground and ObjectivesDrug‐related dreams are commonly reported by individuals in treatment for substance use disorders, which may be distressing. Existing evidence suggests that dream recollection may be influenced by clinically relevant phenomena, such as opioid use and withdrawal, general sleep disturbance, affective symptoms, and chronic pain. However, very few studies have explored drug‐related dreams among individuals who screened positive for opioid use disorder (OUD).MethodsAdults recruited from Amazon Mechanical Turk (MTurk) who screened positive for OUD (N = 154) completed a questionnaire about drug‐related dreams, as well as measures assessing sleep, opioid use history, stress, anxiety, and chronic pain. χ2 analyses, one‐way analysis of variance, and bivariate correlations, correcting for the false discovery rate, were used as appropriate to explore correlates of (1) recollecting a drug‐related dream, and (2) experiencing post‐dream craving and distress.ResultsIndividuals who recollected a past‐week drug‐related dream were more likely to report other recent sleep disturbances, including poorer sleep quality, greater insomnia symptoms, and a higher risk for sleep apnea. Post‐dream craving and distress were both associated with greater insomnia symptoms, poor sleep hygiene behaviors, and greater anxiety symptoms. Individuals who had ever experienced a drug‐related dream (recently, or in their lifetime) were more likely to report a history of severe withdrawal, overdose, and intravenous opioid use.Conclusion and Scientific SignificanceDrug‐related dreams were common among individuals in the present sample and were related to other clinically relevant phenomena. Interventions that treat co‐occurring OUD, pain, sleep symptoms, and affective symptoms may improve overall well‐being in this population.},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021c,

title = {Clinical correlates of drug‐related dreams in opioid use disorder},

author = {Jennifer D. Ellis and Jami L. Mayo and Patrick H. Finan and Charlene E. Gamaldo and Andrew S. Huhn},

doi = {10.1111/ajad.13219},

issn = {1521-0391},

year  = {2022},

date = {2022-01-00},

journal = {American J Addict},

volume = {31},

number = {1},

pages = {37--45},

publisher = {Wiley},

abstract = {AbstractBackground and ObjectivesDrug‐related dreams are commonly reported by individuals in treatment for substance use disorders, which may be distressing. Existing evidence suggests that dream recollection may be influenced by clinically relevant phenomena, such as opioid use and withdrawal, general sleep disturbance, affective symptoms, and chronic pain. However, very few studies have explored drug‐related dreams among individuals who screened positive for opioid use disorder (OUD).MethodsAdults recruited from Amazon Mechanical Turk (MTurk) who screened positive for OUD (N = 154) completed a questionnaire about drug‐related dreams, as well as measures assessing sleep, opioid use history, stress, anxiety, and chronic pain. χ2 analyses, one‐way analysis of variance, and bivariate correlations, correcting for the false discovery rate, were used as appropriate to explore correlates of (1) recollecting a drug‐related dream, and (2) experiencing post‐dream craving and distress.ResultsIndividuals who recollected a past‐week drug‐related dream were more likely to report other recent sleep disturbances, including poorer sleep quality, greater insomnia symptoms, and a higher risk for sleep apnea. Post‐dream craving and distress were both associated with greater insomnia symptoms, poor sleep hygiene behaviors, and greater anxiety symptoms. Individuals who had ever experienced a drug‐related dream (recently, or in their lifetime) were more likely to report a history of severe withdrawal, overdose, and intravenous opioid use.Conclusion and Scientific SignificanceDrug‐related dreams were common among individuals in the present sample and were related to other clinically relevant phenomena. Interventions that treat co‐occurring OUD, pain, sleep symptoms, and affective symptoms may improve overall well‐being in this population.},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Carr2021,

title = {Substance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies},

author = {Meagan M. Carr and Jennifer D. Ellis and Karen K. Saules and Jamie L. Page and Angela Staples and David M. Ledgerwood},

doi = {10.1111/ajad.13149},

issn = {1521-0391},

year  = {2021},

date = {2021-07-00},

journal = {American J Addict},

volume = {30},

number = {4},

pages = {343--350},

publisher = {Wiley},

abstract = {Background and ObjectivesPatients receiving opioid agonist therapies have high rates of psychiatric comorbidity. Some data suggest that comorbidity is associated with poorer treatment outcomes. The current study assessed predictors of multiple putative addictive behaviors among patients receiving opioid agonist therapies.MethodsAdults (N = 176) recruited from an outpatient clinic providing opioid agonist therapy completed self‐report measures of depression, anxiety, impulsivity, adverse childhood events, and the Recognizing Addictive Disorders (RAD) scale, which includes seven subscales assessing symptoms related to alcohol use, drug use, tobacco use, gambling, binge‐eating, hypersexual behavior, and excessive video‐gaming. Linear regression and hurdle models identified significant predictors of RAD subscales. Hurdle models included logistic regression estimation for the presence/absence of symptoms and negative binomial regression for estimation of the severity of symptoms.ResultsMost patients did not report significant symptoms beyond drug or tobacco use. However, 7% to 47% of participants reported some symptoms of other addictive behaviors (subscale score > 0). Higher impulsivity predicted the presence and/or increased severity of symptoms of drug use, gambling, binge‐eating, and hypersexuality. Higher depression significantly predicted increased severity of drug use and binge‐eating symptoms. Increased anxiety predicted lower severity of alcohol use and binge‐eating and higher severity of smoking symptoms.Conclusion and Scientific SignificanceA broader range of potentially addictive symptoms may be present among patients engaged in treatment for opioid use disorder. Few studies have assessed symptoms of binge‐eating, hypersexuality, and excessive video‐gaming among patients receiving opioid agonist therapy. This study contributes to preliminary findings and highlights important future directions. (Am J Addict 2021;00:00–00)},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021d,

title = {The Effects of Anger on Alcohol Demand and Subjective Alcohol Craving},

author = {Jennifer D. Ellis and Emily R. Grekin},

doi = {10.1111/acer.14531},

issn = {1530-0277},

year  = {2021},

date = {2021-02-00},

journal = {Alcoholism Clin & Exp Res},

volume = {45},

number = {2},

pages = {436--445},

publisher = {Wiley},

abstract = {BackgroundAnger and anger‐related traits have been related to alcohol use in both cross‐sectional and prospective studies. However, only a small number of studies have experimentally manipulated anger to examine whether the manipulation of anger influences alcohol craving or the relative reinforcing value of alcohol.MethodsParticipants (N = 231) recruited through Amazon’s MTurk were randomly assigned to a provocation condition or a neutral condition prior to completing both the Alcohol Purchase Task and a self‐report measure of alcohol craving. Linear regression analyses were conducted to examine the effects of the anger induction, trait hostility, frequency of alcohol use in the past month, and relevant demographic characteristics (gender, age, income) on alcohol craving and indices of alcohol demand.ResultsParticipants assigned to the provocation condition had greater PMax (B = 0.17, p = 0.012) and breakpoint (B = 0.18, p = 0.006) values, less elastic demand (B = −0.15, p = 0.020), and lower drinking intensity (B = −0.14, p = 0.025) than participants assigned to the neutral condition. Trait hostility was positively related to OMax (B = 0.22, p = 0.001), intensity of demand (B = 0.27, p < 0.001), and subjective alcohol craving posttask (B = 0.32, p < 0.001), but did not moderate the relationship between condition and outcomes.ConclusionsAlthough most persistence indices of alcohol demand were sensitive to the anger induction, we did not observe higher scores on amplitude indices or subjective craving in the provocation condition relative to the neutral condition. Further investigation into the role which anger plays in alcohol use is warranted.},

keywords = {Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021,

title = {Contingency management for individuals with chronic health conditions: A systematic review and meta-analysis of randomized controlled trials},

author = {Jennifer D. Ellis and Cara A. Struble and Marina C. Fodor and Molly Cairncross and Leslie H. Lundahl and David M. Ledgerwood},

doi = {10.1016/j.brat.2020.103781},

issn = {0005-7967},

year  = {2021},

date = {2021-01-00},

journal = {Behaviour Research and Therapy},

volume = {136},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Experimental and Cognitive Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2020,

title = {Co-occurring opioid and sedative use disorder: Gender differences in use patterns and psychiatric co-morbidities in the United States},

author = {Jennifer D. Ellis and Brian P. Pittman and Sherry A. McKee},

doi = {10.1016/j.jsat.2020.108012},

issn = {0740-5472},

year  = {2020},

date = {2020-07-00},

journal = {Journal of Substance Abuse Treatment},

volume = {114},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Pshychiatric Mental Health, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Lister2020,

title = {Opioid prescribing and opioid-overdose deaths in Michigan: Urban-rural comparisons and changes across 2013–2017},

author = {Jamey J. Lister and Jennifer D. Ellis and Miyoung Yoon},

doi = {10.1016/j.abrep.2019.100234},

issn = {2352-8532},

year  = {2020},

date = {2020-06-00},

journal = {Addictive Behaviors Reports},

volume = {11},

publisher = {Elsevier BV},

keywords = {Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Lister2019,

title = {A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States},

author = {Jamey J. Lister and Addie Weaver and Jennifer D. Ellis and Joseph A. Himle and David M. Ledgerwood},

doi = {10.1080/00952990.2019.1694536},

issn = {1097-9891},

year  = {2020},

date = {2020-05-03},

journal = {The American Journal of Drug and Alcohol Abuse},

volume = {46},

number = {3},

pages = {273--288},

publisher = {Informa UK Limited},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Carr2020,

title = {Development and Validation of the Recognizing Addictive Disorders Scale: A Transdiagnostic Measure of Substance-Related and Other Addictive Disorders},

author = {Meagan M. Carr and Karen K. Saules and Jennifer D. Ellis and Angela Staples and David M. Ledgerwood and Tamara M. Loverich},

doi = {10.1080/10826084.2020.1797806},

issn = {1532-2491},

year  = {2020},

date = {2020-03-03},

journal = {Substance Use & Misuse},

volume = {55},

number = {13},

pages = {2194--2204},

publisher = {Informa UK Limited},

keywords = {Environmental and Occupational Health, Health (social science), Medicine (miscellaneous), Psychiatry and Mental health, Public Health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2019d,

title = {Correlates of substance use in pregnant women under community supervision after conviction for a criminal offence: The role of psychological distress},

author = {Jennifer Danielle Ellis and Emily R. Grekin and Stella M. Resko},

doi = {10.1002/cbm.2133},

issn = {1471-2857},

year  = {2019},

date = {2019-12-00},

journal = {Criminal Behav Ment Health},

volume = {29},

number = {5-6},

pages = {261--275},

publisher = {Wiley},

abstract = {AbstractBackgroundBeing pregnant while under community supervision after conviction for a criminal offence can be a highly stressful experience, and pregnant women under community supervision are at an elevated risk for substance use.Aims/HypothesesTo test for relationships between psychological distress and use of tobacco, alcohol, or marijuana during the month prior to a research assessment among pregnant women under community supervision, controlling for demographic characteristics.MethodsData from the National Survey on Drug Use and Health were aggregated for the years 2008–2016, inclusive. Logistic regression analyses were conducted to examine correlates of past‐month use of each substance.ResultsOf all 505,796 people in the survey, 6,974 were pregnant women of whom 280 reported being under community supervision for a criminal offence; relevant data were available for 271 of these cases. The pregnant women under community supervision reported higher rates of past‐month substance use of each kind and of psychological distress than pregnant women not under community supervision. Past‐month serious psychological distress, but not remitted psychological distress, corresponded strongly with past‐month alcohol use even when controlling for demographic characteristics and other substance use.ConclusionsOur findings add to the very sparse literature about a group of women likely to be exceptionally vulnerable during pregnancy and underscore the importance of screening for symptoms of substance use and of psychological distress amongst them. Among women under community supervision, alcohol use was less likely in the second or third trimester than the first, but as those using alcohol were more likely to report past month psychological distress, it may be important to provide additional resources and treatment services for these women.},

keywords = {General Medicine, Pathology and Forensic Medicine, Psychiatry and Mental health, Psychology (miscellaneous)},

pubstate = {published},

tppubtype = {article}

}

@article{Rabinowitz2023,

title = {Patterns of demoralization and anhedonia during early substance use disorder treatment and associations with treatment attrition},

author = {Jill A. Rabinowitz and Jennifer D. Ellis and Justin C. Strickland and Martin Hochheimer and Yijun Zhou and Andrea S. Young and Brenda Curtis and Andrew S. Huhn},

doi = {10.1016/j.jad.2023.05.029},

issn = {0165-0327},

year  = {2023},

date = {2023-08-00},

journal = {Journal of Affective Disorders},

volume = {335},

pages = {248--255},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2023b,

title = {Latent patterns of sleep disturbance, pain impact, and depressive symptoms in residential substance use treatment},

author = {Jennifer D. Ellis and Jill A. Rabinowitz. and Justin C. Strickland and Neha Skandan and J. Gregory Hobelmann and Patrick H. Finan and Andrew S. Huhn},

doi = {10.1016/j.drugalcdep.2023.109903},

issn = {0376-8716},

year  = {2023},

date = {2023-07-00},

journal = {Drug and Alcohol Dependence},

volume = {248},

publisher = {Elsevier BV},

keywords = {Pharmacology, Pharmacology (medical), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2023c,

title = {Latent patterns of sleep disturbance, pain impact, and depressive symptoms in residential substance use treatment},

author = {Jennifer D. Ellis and Jill A. Rabinowitz. and Justin C. Strickland and Neha Skandan and J. Gregory Hobelmann and Patrick H. Finan and Andrew S. Huhn},

doi = {10.1016/j.drugalcdep.2023.109903},

issn = {0376-8716},

year  = {2023},

date = {2023-07-00},

journal = {Drug and Alcohol Dependence},

volume = {248},

publisher = {Elsevier BV},

keywords = {Pharmacology, Pharmacology (medical), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2023d,

title = {Exploring potential moderators of depressive symptoms and treatment outcomes among patients with opioid use disorder},

author = {Jennifer D. Ellis and Jamey J. Lister and Michael J.A. Wohl and Mark K. Greenwald and David M. Ledgerwood},

doi = {10.1016/j.addbeh.2022.107604},

issn = {0306-4603},

year  = {2023},

date = {2023-05-00},

journal = {Addictive Behaviors},

volume = {140},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Carr2022,

title = {Childhood Adversity, Addiction Severity, and Comorbidity Among Patients Receiving Opioid Use Disorder Treatment},

author = {Meagan M. Carr and Jennifer D. Ellis and Karen K. Saules and David M. Ledgerwood},

doi = {10.1097/nmd.0000000000001581},

issn = {1539-736X},

year  = {2023},

date = {2023-00-00},

journal = {J Nerv Ment Dis},

volume = {211},

number = {2},

pages = {150--156},

publisher = {Ovid Technologies (Wolters Kluwer Health)},

abstract = {Abstract

          Patients in opioid use disorder (OUD) treatment report high rates of childhood adversity, and women experience greater exposure to certain types of childhood adversity (e.g., sexual abuse). Childhood adversity is associated with clinical severity, but the mechanisms explaining this association are not well understood. Participants (N = 171) in opioid agonist treatment completed measures of childhood adversity, emotion regulation, and clinical severity (i.e., addictive behaviors, depression, and anxiety). Women endorsed greater childhood adversity and higher current psychopathology than men. The association between childhood adversity and clinical severity varied as a function of symptom type, although emotion regulation was a strong predictor in all models. Women reported higher levels of anxiety after controlling for covariates, childhood adversity, and emotion dysregulation. Future research should investigate treatment strategies to address emotion dysregulation among patients in OUD treatment, particularly women who may present with greater childhood adversity exposure and anxiety.},

keywords = {Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2022c,

title = {Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder},

author = {Jennifer D. Ellis and Chung Jung Mun and David H. Epstein and Karran A. Phillips and Patrick H. Finan and Kenzie L. Preston},

doi = {10.1038/s41386-022-01352-y},

issn = {1740-634X},

year  = {2022},

date = {2022-09-00},

journal = {Neuropsychopharmacol.},

volume = {47},

number = {10},

pages = {1836--1843},

publisher = {Springer Science and Business Media LLC},

keywords = {Pharmacology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Lister2022,

title = {Protective Factor Predictors of Abstinence and Retention in Patients Receiving Methadone Treatment for Opioid Use Disorder},

author = {Jamey J. Lister and Jennifer D. Ellis and Cara A. Struble and David M. Ledgerwood and Mark K. Greenwald},

doi = {10.1007/s11469-022-00893-z},

issn = {1557-1882},

year  = {2022},

date = {2022-08-08},

journal = {Int J Ment Health Addiction},

publisher = {Springer Science and Business Media LLC},

keywords = {Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Huhn2022,

title = {Patient-reported sleep outcomes in randomized-controlled trials in persons with substance use disorders: A systematic review},

author = {Andrew S. Huhn and Jennifer D. Ellis and Kelly E. Dunn and Dennis J. Sholler and Paula Tabaschek and Rachel Burns and Eric C. Strain},

doi = {10.1016/j.drugalcdep.2022.109508},

issn = {0376-8716},

year  = {2022},

date = {2022-08-00},

journal = {Drug and Alcohol Dependence},

volume = {237},

publisher = {Elsevier BV},

keywords = {Pharmacology, Pharmacology (medical), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Huhn2022b,

title = {Objective sleep outcomes in randomized-controlled trials in persons with substance use disorders: A systematic review},

author = {Andrew S. Huhn and Kelly E. Dunn and Jennifer D. Ellis and Dennis J. Sholler and Paula Tabaschek and Rachel Burns and Eric C. Strain},

doi = {10.1016/j.drugalcdep.2022.109509},

issn = {0376-8716},

year  = {2022},

date = {2022-08-00},

journal = {Drug and Alcohol Dependence},

volume = {237},

publisher = {Elsevier BV},

keywords = {Pharmacology, Pharmacology (medical), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2022b,

title = {Latent trajectories of anxiety and depressive symptoms among adults in early treatment for nonmedical opioid use},

author = {Jennifer D. Ellis and Jill A. Rabinowitz and Jonathan Wells and Fangyu Liu and Patrick H. Finan and Michael D. Stein and Denis G. Antoine II and Gregory J. Hobelmann and Andrew S. Huhn},

doi = {10.1016/j.jad.2021.12.004},

issn = {0165-0327},

year  = {2022},

date = {2022-02-00},

journal = {Journal of Affective Disorders},

volume = {299},

pages = {223--232},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021b,

title = {Clinical correlates of drug‐related dreams in opioid use disorder},

author = {Jennifer D. Ellis and Jami L. Mayo and Patrick H. Finan and Charlene E. Gamaldo and Andrew S. Huhn},

doi = {10.1111/ajad.13219},

issn = {1521-0391},

year  = {2022},

date = {2022-01-00},

journal = {American J Addict},

volume = {31},

number = {1},

pages = {37--45},

publisher = {Wiley},

abstract = {AbstractBackground and ObjectivesDrug‐related dreams are commonly reported by individuals in treatment for substance use disorders, which may be distressing. Existing evidence suggests that dream recollection may be influenced by clinically relevant phenomena, such as opioid use and withdrawal, general sleep disturbance, affective symptoms, and chronic pain. However, very few studies have explored drug‐related dreams among individuals who screened positive for opioid use disorder (OUD).MethodsAdults recruited from Amazon Mechanical Turk (MTurk) who screened positive for OUD (N = 154) completed a questionnaire about drug‐related dreams, as well as measures assessing sleep, opioid use history, stress, anxiety, and chronic pain. χ2 analyses, one‐way analysis of variance, and bivariate correlations, correcting for the false discovery rate, were used as appropriate to explore correlates of (1) recollecting a drug‐related dream, and (2) experiencing post‐dream craving and distress.ResultsIndividuals who recollected a past‐week drug‐related dream were more likely to report other recent sleep disturbances, including poorer sleep quality, greater insomnia symptoms, and a higher risk for sleep apnea. Post‐dream craving and distress were both associated with greater insomnia symptoms, poor sleep hygiene behaviors, and greater anxiety symptoms. Individuals who had ever experienced a drug‐related dream (recently, or in their lifetime) were more likely to report a history of severe withdrawal, overdose, and intravenous opioid use.Conclusion and Scientific SignificanceDrug‐related dreams were common among individuals in the present sample and were related to other clinically relevant phenomena. Interventions that treat co‐occurring OUD, pain, sleep symptoms, and affective symptoms may improve overall well‐being in this population.},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021c,

title = {Clinical correlates of drug‐related dreams in opioid use disorder},

author = {Jennifer D. Ellis and Jami L. Mayo and Patrick H. Finan and Charlene E. Gamaldo and Andrew S. Huhn},

doi = {10.1111/ajad.13219},

issn = {1521-0391},

year  = {2022},

date = {2022-01-00},

journal = {American J Addict},

volume = {31},

number = {1},

pages = {37--45},

publisher = {Wiley},

abstract = {AbstractBackground and ObjectivesDrug‐related dreams are commonly reported by individuals in treatment for substance use disorders, which may be distressing. Existing evidence suggests that dream recollection may be influenced by clinically relevant phenomena, such as opioid use and withdrawal, general sleep disturbance, affective symptoms, and chronic pain. However, very few studies have explored drug‐related dreams among individuals who screened positive for opioid use disorder (OUD).MethodsAdults recruited from Amazon Mechanical Turk (MTurk) who screened positive for OUD (N = 154) completed a questionnaire about drug‐related dreams, as well as measures assessing sleep, opioid use history, stress, anxiety, and chronic pain. χ2 analyses, one‐way analysis of variance, and bivariate correlations, correcting for the false discovery rate, were used as appropriate to explore correlates of (1) recollecting a drug‐related dream, and (2) experiencing post‐dream craving and distress.ResultsIndividuals who recollected a past‐week drug‐related dream were more likely to report other recent sleep disturbances, including poorer sleep quality, greater insomnia symptoms, and a higher risk for sleep apnea. Post‐dream craving and distress were both associated with greater insomnia symptoms, poor sleep hygiene behaviors, and greater anxiety symptoms. Individuals who had ever experienced a drug‐related dream (recently, or in their lifetime) were more likely to report a history of severe withdrawal, overdose, and intravenous opioid use.Conclusion and Scientific SignificanceDrug‐related dreams were common among individuals in the present sample and were related to other clinically relevant phenomena. Interventions that treat co‐occurring OUD, pain, sleep symptoms, and affective symptoms may improve overall well‐being in this population.},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Carr2021,

title = {Substance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies},

author = {Meagan M. Carr and Jennifer D. Ellis and Karen K. Saules and Jamie L. Page and Angela Staples and David M. Ledgerwood},

doi = {10.1111/ajad.13149},

issn = {1521-0391},

year  = {2021},

date = {2021-07-00},

journal = {American J Addict},

volume = {30},

number = {4},

pages = {343--350},

publisher = {Wiley},

abstract = {Background and ObjectivesPatients receiving opioid agonist therapies have high rates of psychiatric comorbidity. Some data suggest that comorbidity is associated with poorer treatment outcomes. The current study assessed predictors of multiple putative addictive behaviors among patients receiving opioid agonist therapies.MethodsAdults (N = 176) recruited from an outpatient clinic providing opioid agonist therapy completed self‐report measures of depression, anxiety, impulsivity, adverse childhood events, and the Recognizing Addictive Disorders (RAD) scale, which includes seven subscales assessing symptoms related to alcohol use, drug use, tobacco use, gambling, binge‐eating, hypersexual behavior, and excessive video‐gaming. Linear regression and hurdle models identified significant predictors of RAD subscales. Hurdle models included logistic regression estimation for the presence/absence of symptoms and negative binomial regression for estimation of the severity of symptoms.ResultsMost patients did not report significant symptoms beyond drug or tobacco use. However, 7% to 47% of participants reported some symptoms of other addictive behaviors (subscale score > 0). Higher impulsivity predicted the presence and/or increased severity of symptoms of drug use, gambling, binge‐eating, and hypersexuality. Higher depression significantly predicted increased severity of drug use and binge‐eating symptoms. Increased anxiety predicted lower severity of alcohol use and binge‐eating and higher severity of smoking symptoms.Conclusion and Scientific SignificanceA broader range of potentially addictive symptoms may be present among patients engaged in treatment for opioid use disorder. Few studies have assessed symptoms of binge‐eating, hypersexuality, and excessive video‐gaming among patients receiving opioid agonist therapy. This study contributes to preliminary findings and highlights important future directions. (Am J Addict 2021;00:00–00)},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021d,

title = {The Effects of Anger on Alcohol Demand and Subjective Alcohol Craving},

author = {Jennifer D. Ellis and Emily R. Grekin},

doi = {10.1111/acer.14531},

issn = {1530-0277},

year  = {2021},

date = {2021-02-00},

journal = {Alcoholism Clin & Exp Res},

volume = {45},

number = {2},

pages = {436--445},

publisher = {Wiley},

abstract = {BackgroundAnger and anger‐related traits have been related to alcohol use in both cross‐sectional and prospective studies. However, only a small number of studies have experimentally manipulated anger to examine whether the manipulation of anger influences alcohol craving or the relative reinforcing value of alcohol.MethodsParticipants (N = 231) recruited through Amazon’s MTurk were randomly assigned to a provocation condition or a neutral condition prior to completing both the Alcohol Purchase Task and a self‐report measure of alcohol craving. Linear regression analyses were conducted to examine the effects of the anger induction, trait hostility, frequency of alcohol use in the past month, and relevant demographic characteristics (gender, age, income) on alcohol craving and indices of alcohol demand.ResultsParticipants assigned to the provocation condition had greater PMax (B = 0.17, p = 0.012) and breakpoint (B = 0.18, p = 0.006) values, less elastic demand (B = −0.15, p = 0.020), and lower drinking intensity (B = −0.14, p = 0.025) than participants assigned to the neutral condition. Trait hostility was positively related to OMax (B = 0.22, p = 0.001), intensity of demand (B = 0.27, p < 0.001), and subjective alcohol craving posttask (B = 0.32, p < 0.001), but did not moderate the relationship between condition and outcomes.ConclusionsAlthough most persistence indices of alcohol demand were sensitive to the anger induction, we did not observe higher scores on amplitude indices or subjective craving in the provocation condition relative to the neutral condition. Further investigation into the role which anger plays in alcohol use is warranted.},

keywords = {Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021,

title = {Contingency management for individuals with chronic health conditions: A systematic review and meta-analysis of randomized controlled trials},

author = {Jennifer D. Ellis and Cara A. Struble and Marina C. Fodor and Molly Cairncross and Leslie H. Lundahl and David M. Ledgerwood},

doi = {10.1016/j.brat.2020.103781},

issn = {0005-7967},

year  = {2021},

date = {2021-01-00},

journal = {Behaviour Research and Therapy},

volume = {136},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Experimental and Cognitive Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2020,

title = {Co-occurring opioid and sedative use disorder: Gender differences in use patterns and psychiatric co-morbidities in the United States},

author = {Jennifer D. Ellis and Brian P. Pittman and Sherry A. McKee},

doi = {10.1016/j.jsat.2020.108012},

issn = {0740-5472},

year  = {2020},

date = {2020-07-00},

journal = {Journal of Substance Abuse Treatment},

volume = {114},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Pshychiatric Mental Health, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Lister2020,

title = {Opioid prescribing and opioid-overdose deaths in Michigan: Urban-rural comparisons and changes across 2013–2017},

author = {Jamey J. Lister and Jennifer D. Ellis and Miyoung Yoon},

doi = {10.1016/j.abrep.2019.100234},

issn = {2352-8532},

year  = {2020},

date = {2020-06-00},

journal = {Addictive Behaviors Reports},

volume = {11},

publisher = {Elsevier BV},

keywords = {Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Lister2019,

title = {A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States},

author = {Jamey J. Lister and Addie Weaver and Jennifer D. Ellis and Joseph A. Himle and David M. Ledgerwood},

doi = {10.1080/00952990.2019.1694536},

issn = {1097-9891},

year  = {2020},

date = {2020-05-03},

journal = {The American Journal of Drug and Alcohol Abuse},

volume = {46},

number = {3},

pages = {273--288},

publisher = {Informa UK Limited},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Carr2020,

title = {Development and Validation of the Recognizing Addictive Disorders Scale: A Transdiagnostic Measure of Substance-Related and Other Addictive Disorders},

author = {Meagan M. Carr and Karen K. Saules and Jennifer D. Ellis and Angela Staples and David M. Ledgerwood and Tamara M. Loverich},

doi = {10.1080/10826084.2020.1797806},

issn = {1532-2491},

year  = {2020},

date = {2020-03-03},

journal = {Substance Use & Misuse},

volume = {55},

number = {13},

pages = {2194--2204},

publisher = {Informa UK Limited},

keywords = {Environmental and Occupational Health, Health (social science), Medicine (miscellaneous), Psychiatry and Mental health, Public Health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2019d,

title = {Correlates of substance use in pregnant women under community supervision after conviction for a criminal offence: The role of psychological distress},

author = {Jennifer Danielle Ellis and Emily R. Grekin and Stella M. Resko},

doi = {10.1002/cbm.2133},

issn = {1471-2857},

year  = {2019},

date = {2019-12-00},

journal = {Criminal Behav Ment Health},

volume = {29},

number = {5-6},

pages = {261--275},

publisher = {Wiley},

abstract = {AbstractBackgroundBeing pregnant while under community supervision after conviction for a criminal offence can be a highly stressful experience, and pregnant women under community supervision are at an elevated risk for substance use.Aims/HypothesesTo test for relationships between psychological distress and use of tobacco, alcohol, or marijuana during the month prior to a research assessment among pregnant women under community supervision, controlling for demographic characteristics.MethodsData from the National Survey on Drug Use and Health were aggregated for the years 2008–2016, inclusive. Logistic regression analyses were conducted to examine correlates of past‐month use of each substance.ResultsOf all 505,796 people in the survey, 6,974 were pregnant women of whom 280 reported being under community supervision for a criminal offence; relevant data were available for 271 of these cases. The pregnant women under community supervision reported higher rates of past‐month substance use of each kind and of psychological distress than pregnant women not under community supervision. Past‐month serious psychological distress, but not remitted psychological distress, corresponded strongly with past‐month alcohol use even when controlling for demographic characteristics and other substance use.ConclusionsOur findings add to the very sparse literature about a group of women likely to be exceptionally vulnerable during pregnancy and underscore the importance of screening for symptoms of substance use and of psychological distress amongst them. Among women under community supervision, alcohol use was less likely in the second or third trimester than the first, but as those using alcohol were more likely to report past month psychological distress, it may be important to provide additional resources and treatment services for these women.},

keywords = {General Medicine, Pathology and Forensic Medicine, Psychiatry and Mental health, Psychology (miscellaneous)},

pubstate = {published},

tppubtype = {article}

}

@article{Resko2019,

title = {Understanding Public Attitudes Toward Cannabis Legalization: Qualitative Findings From a Statewide Survey},

author = {Stella Resko and Jennifer Ellis and Theresa J. Early and Kathryn A. Szechy and Brooke Rodriguez and Elizabeth Agius},

doi = {10.1080/10826084.2018.1543327},

issn = {1532-2491},

year  = {2019},

date = {2019-07-03},

journal = {Substance Use & Misuse},

volume = {54},

number = {8},

pages = {1247--1259},

publisher = {Informa UK Limited},

keywords = {Environmental and Occupational Health, Health (social science), Medicine (miscellaneous), Psychiatry and Mental health, Public Health},

pubstate = {published},

tppubtype = {article}

}

@article{Resko2019b,

title = {Understanding Public Attitudes Toward Cannabis Legalization: Qualitative Findings From a Statewide Survey},

author = {Stella Resko and Jennifer Ellis and Theresa J. Early and Kathryn A. Szechy and Brooke Rodriguez and Elizabeth Agius},

doi = {10.1080/10826084.2018.1543327},

issn = {1532-2491},

year  = {2019},

date = {2019-07-03},

journal = {Substance Use & Misuse},

volume = {54},

number = {8},

pages = {1247--1259},

publisher = {Informa UK Limited},

keywords = {Environmental and Occupational Health, Health (social science), Medicine (miscellaneous), Psychiatry and Mental health, Public Health},

pubstate = {published},

tppubtype = {article}

}

@article{Resko2019c,

title = {Understanding Public Attitudes Toward Cannabis Legalization: Qualitative Findings From a Statewide Survey},

author = {Stella Resko and Jennifer Ellis and Theresa J. Early and Kathryn A. Szechy and Brooke Rodriguez and Elizabeth Agius},

doi = {10.1080/10826084.2018.1543327},

issn = {1532-2491},

year  = {2019},

date = {2019-07-03},

journal = {Substance Use & Misuse},

volume = {54},

number = {8},

pages = {1247--1259},

publisher = {Informa UK Limited},

keywords = {Environmental and Occupational Health, Health (social science), Medicine (miscellaneous), Psychiatry and Mental health, Public Health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2019b,

title = {Correlates of Treatment Retention and Opioid Misuse Among Postpartum Women in Methadone Treatment},

author = {Jennifer D. Ellis and Molly Cairncross and Cara A. Struble and Meagan M. Carr and David M. Ledgerwood and Leslie H. Lundahl},

doi = {10.1097/adm.0000000000000467},

issn = {1935-3227},

year  = {2019},

date = {2019-00-00},

volume = {13},

number = {2},

pages = {153--158},

publisher = {Ovid Technologies (Wolters Kluwer Health)},

abstract = {

            Objectives:

            The postpartum period is a particularly challenging time for women in methadone treatment. Unfortunately, this is also the time when women are vulnerable to treatment discontinuation and opioid misuse. The purpose of the present exploratory study was to examine demographic, treatment, and delivery factors that may be associated with postbirth retention in treatment and opioid misuse.

          

          

            Methods:

            A chart review was conducted among postpartum women (n = 81) receiving opioid agonist treatment during pregnancy.

          

          

            Results:

            Results revealed that treatment discharge and postbirth opioid misuse were common after delivery. Longer treatment duration before delivery was associated with a lower likelihood of opioid misuse in the month after delivery. Women who delivered via cesarean section and received a discharge opioid medication were also more likely to engage in opioid misuse (ie, providing an opioid-positive urine toxicology screen outside the window of detection for the discharge opioid prescription) in the month after delivery.

          

          

            Conclusions:

            Increasing support to minimize the likelihood of treatment discontinuation or opioid misuse may be particularly important in this period, especially for this vulnerable group.

          },

keywords = {Pharmacology (medical), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Cairncross2019,

title = {Clinical and Personality Characteristics of Problem and Pathological Gamblers With and Without Symptoms of Adult ADHD},

author = {Molly Cairncross and Aleks Milosevic and Cara A. Struble and Jennifer D. Ellis and David M. Ledgerwood},

doi = {10.1097/nmd.0000000000000959},

issn = {1539-736X},

year  = {2019},

date = {2019-00-00},

journal = {J Nerv Ment Dis},

volume = {207},

number = {4},

pages = {246--254},

publisher = {Ovid Technologies (Wolters Kluwer Health)},

abstract = {Abstract

          The study examined the differential clinical and personality characteristics of problem and pathological gamblers (PPGs) with and without clinically significant symptoms of adult attention deficit hyperactive disorder (ADHD). Adults (N = 150, n = 75 women) with PPG were assessed by the SCID-IV, Conners' Adult ADHD Rating Scales, Multidimensional Personality Questionnaire, Gambling Motivation Questionnaire, and the Barratt Impulsiveness Scale. PPGs who reported symptoms of ADHD were more likely to be male, endorse psychiatric comorbidities (i.e., alcohol dependence, anxiety disorders, and antisocial personality disorder), report maladaptive personality traits (i.e., higher negative emotionality and lower positive emotionality), as well as higher impulsivity (attention impulsiveness, motor impulsiveness, and nonplanning impulsiveness). PPGs with symptoms of ADHD reported gambling for social, coping, and enhancement reasons. A multivariate binary logistic regression revealed that sex, higher scores on social reasons for gambling, and lack of premeditation were associated with an increased likelihood of reporting ADHD symptoms. The findings demonstrate important differences of PPGs with symptoms of ADHD and provide information for treatment consideration.},

keywords = {Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2019c,

title = {Correlates of Treatment Retention and Opioid Misuse Among Postpartum Women in Methadone Treatment},

author = {Jennifer D. Ellis and Molly Cairncross and Cara A. Struble and Meagan M. Carr and David M. Ledgerwood and Leslie H. Lundahl},

doi = {10.1097/adm.0000000000000467},

issn = {1935-3227},

year  = {2019},

date = {2019-00-00},

volume = {13},

number = {2},

pages = {153--158},

publisher = {Ovid Technologies (Wolters Kluwer Health)},

abstract = {

            Objectives:

            The postpartum period is a particularly challenging time for women in methadone treatment. Unfortunately, this is also the time when women are vulnerable to treatment discontinuation and opioid misuse. The purpose of the present exploratory study was to examine demographic, treatment, and delivery factors that may be associated with postbirth retention in treatment and opioid misuse.

          

          

            Methods:

            A chart review was conducted among postpartum women (n = 81) receiving opioid agonist treatment during pregnancy.

          

          

            Results:

            Results revealed that treatment discharge and postbirth opioid misuse were common after delivery. Longer treatment duration before delivery was associated with a lower likelihood of opioid misuse in the month after delivery. Women who delivered via cesarean section and received a discharge opioid medication were also more likely to engage in opioid misuse (ie, providing an opioid-positive urine toxicology screen outside the window of detection for the discharge opioid prescription) in the month after delivery.

          

          

            Conclusions:

            Increasing support to minimize the likelihood of treatment discontinuation or opioid misuse may be particularly important in this period, especially for this vulnerable group.

          },

keywords = {Pharmacology (medical), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Cairncross2019b,

title = {Clinical and Personality Characteristics of Problem and Pathological Gamblers With and Without Symptoms of Adult ADHD},

author = {Molly Cairncross and Aleks Milosevic and Cara A. Struble and Jennifer D. Ellis and David M. Ledgerwood},

doi = {10.1097/nmd.0000000000000959},

issn = {1539-736X},

year  = {2019},

date = {2019-00-00},

journal = {J Nerv Ment Dis},

volume = {207},

number = {4},

pages = {246--254},

publisher = {Ovid Technologies (Wolters Kluwer Health)},

abstract = {Abstract

          The study examined the differential clinical and personality characteristics of problem and pathological gamblers (PPGs) with and without clinically significant symptoms of adult attention deficit hyperactive disorder (ADHD). Adults (N = 150, n = 75 women) with PPG were assessed by the SCID-IV, Conners' Adult ADHD Rating Scales, Multidimensional Personality Questionnaire, Gambling Motivation Questionnaire, and the Barratt Impulsiveness Scale. PPGs who reported symptoms of ADHD were more likely to be male, endorse psychiatric comorbidities (i.e., alcohol dependence, anxiety disorders, and antisocial personality disorder), report maladaptive personality traits (i.e., higher negative emotionality and lower positive emotionality), as well as higher impulsivity (attention impulsiveness, motor impulsiveness, and nonplanning impulsiveness). PPGs with symptoms of ADHD reported gambling for social, coping, and enhancement reasons. A multivariate binary logistic regression revealed that sex, higher scores on social reasons for gambling, and lack of premeditation were associated with an increased likelihood of reporting ADHD symptoms. The findings demonstrate important differences of PPGs with symptoms of ADHD and provide information for treatment consideration.},

keywords = {Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2017b,

title = {Executive Function in Problem Gamblers with and without History of Depression},

author = {Jennifer D. Ellis and Meagan M. Carr and David M. Ledgerwood},

doi = {10.1007/s11469-017-9804-5},

issn = {1557-1882},

year  = {2018},

date = {2018-10-00},

journal = {Int J Ment Health Addiction},

volume = {16},

number = {5},

pages = {1085--1094},

publisher = {Springer Science and Business Media LLC},

keywords = {Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2017c,

title = {Executive Function in Problem Gamblers with and without History of Depression},

author = {Jennifer D. Ellis and Meagan M. Carr and David M. Ledgerwood},

doi = {10.1007/s11469-017-9804-5},

issn = {1557-1882},

year  = {2018},

date = {2018-10-00},

journal = {Int J Ment Health Addiction},

volume = {16},

number = {5},

pages = {1085--1094},

publisher = {Springer Science and Business Media LLC},

keywords = {Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2018,

title = {Client and clinician-rated characteristics of problem gamblers with and without history of gambling-related illegal behaviors},

author = {Jennifer D. Ellis and Jamey J. Lister and Cara A. Struble and Molly Cairncross and Meagan M. Carr and David M. Ledgerwood},

doi = {10.1016/j.addbeh.2018.03.017},

issn = {0306-4603},

year  = {2018},

date = {2018-09-00},

journal = {Addictive Behaviors},

volume = {84},

pages = {1--6},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2018b,

title = {Client and clinician-rated characteristics of problem gamblers with and without history of gambling-related illegal behaviors},

author = {Jennifer D. Ellis and Jamey J. Lister and Cara A. Struble and Molly Cairncross and Meagan M. Carr and David M. Ledgerwood},

doi = {10.1016/j.addbeh.2018.03.017},

issn = {0306-4603},

year  = {2018},

date = {2018-09-00},

journal = {Addictive Behaviors},

volume = {84},

pages = {1--6},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Hand2017,

title = {Contingency management interventions for tobacco and other substance use disorders in pregnancy.},

author = {Dennis J. Hand and Jennifer D. Ellis and Meagan M. Carr and Diane J. Abatemarco and David M. Ledgerwood},

doi = {10.1037/adb0000291},

issn = {1939-1501},

year  = {2017},

date = {2017-12-00},

journal = {Psychology of Addictive Behaviors},

volume = {31},

number = {8},

pages = {907--921},

publisher = {American Psychological Association (APA)},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}